ADMA BIOLOGICS, INC.

financial.report · SEC EDGAR

This page reproduces a recorded source event. It is not a live quote, forecast, recommendation or legal conclusion.

Event type

financial.report

Occurred

2025-09-30

Reported

2025-11-05

Disclosure lag

36 days

Context

links are based on the recorded entity type

Field	Recorded value
Entity	ADMA BIOLOGICS, INC.
Source	SEC EDGAR ↗
Source identifier	companyfacts/CIK0001368514/2026-07-26
Event ID	#29231

Recorded payload

JSON payload as stored after parsing

{
  "accession": "0001140361-25-040578",
  "canonical_covered": 12,
  "canonical_total": 12,
  "fiscal_period": "Q3",
  "fiscal_year": 2025,
  "form": "10-Q",
  "mapped_tag_share": 0.03811659192825112,
  "metrics": {
    "cash_and_equivalents": 61385000,
    "earnings_per_share_basic": 0.15,
    "earnings_per_share_diluted": 0.15,
    "gross_profit": 75626000,
    "net_income": 36428000,
    "operating_income": 51012000,
    "revenue": 134224000,
    "shareholders_equity": 431186000,
    "shares_outstanding": 238332393,
    "total_assets": 568687000,
    "total_liabilities": 137501000
  },
  "metrics_reported": 11,
  "period_end": "2025-09-30"
}

Source: SEC EDGAR · as of 2025-11-05T00:00:00Z